(Q48895787)

English

Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience.

scientific article published in June 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/15880378

Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience. (English)

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/15880378

1 reference

based on heuristic

inferred from title

blood–brain barrier

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Annick Desjardins

2

object named as

Annick Desjardins

1 reference

Europe PubMed Central

16 February 2018

1

object named as

David Fortin

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/15880378

author name string

Andrew Benko

3

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/15880378

Theophylle Niyonsega

4

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/15880378

Marie Boudrias

5

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/15880378

language of work or name

0 references

publication date

1 June 2005

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/15880378

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/15880378

103

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/15880378

12

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/15880378

2606-2615

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/15880378

Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21112

21 January 2018

Blood-tumor barrier disruption controversies.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21112

21 January 2018

Chemotherapeutic dose intensification for treatment of malignant brain tumors: recent developments and future directions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21112

7 January 2021

based on heuristic

inferred from DOI database lookup

Oligodendroglioma: an appraisal of recent data pertaining to diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21112

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21112

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21112

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21112

7 January 2021

based on heuristic

inferred from DOI database lookup

Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21112

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug delivery to the brain

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21112

7 January 2021

based on heuristic

inferred from DOI database lookup

Testing of a hypothesis for osmotic opening of the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21112

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21112

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravascular streaming during carotid artery infusions. Demonstration in humans and reduction using diastole-phased pulsatile administration.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21112

7 January 2021

based on heuristic

inferred from DOI database lookup

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21112

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21112

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting neurotherapeutic agents through the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21112

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate disposition following disruption of the blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21112

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased delivery of tumor-specific monoclonal antibodies to brain after osmotic blood-brain barrier modification in patients with melanoma metastatic to the central nervous system.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21112

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruption.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21112

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21112

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantification of early blood-brain barrier disruption by in situ brain perfusion technique

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21112

7 January 2021

based on heuristic

inferred from DOI database lookup

PCV for oligodendroglial tumors: in search of prognostic factors for response and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21112

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful chemotherapy for recurrent malignant oligodendroglioma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21112

7 January 2021

based on heuristic

inferred from DOI database lookup

[The blood-brain barrier should not be underestimated in neuro-oncology]

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21112

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.21112

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/15880378

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/15880378

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48895787&oldid=1628244405"